Journey Medical Corp
DERM· Nasdaq
Released Aug 12, 2026, after the close
10-Q filed Aug 12, 2026, 43 days after period end · 0001104659-26-094948
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $17.84M | $15.01M | $14.86M | $16.96M |
| Net Income | -$312.00K | -$3.80M | -$3.36M | -$8.36M |
| EPS Diluted |
Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.16 |
| -$0.17 |
| -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.